Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Researchers from the University of Michigan and Northwestern University are studying people's experiences with swelling caused by Nephrotic Syndrome. Interviews with patients (child and adult) and parents of young children will be conducted. The information collected from the interviews will be used to develop a survey to use when testing new medications for Nephrotic Syndrome.
Please consider participating in a 1-hour long interview with the Prepare-NS research study to discuss children and adults experiences with swelling.
Full description
This registration includes concept elicitation, analysis and creation of complementary survey measures focused on edema/fluid overload of nephrotic syndrome. The measures to be developed include an Observer Reported Outcome (ObsRO) and Patient Reported Outcome (PRO). The ObsRO and PRO substudies are Institutional Review Board (IRB) approved at release.
The researcher's goal is to produce core outcome sets of patient-rated and observer reported Fluid Overload (edema) measures that can be applied across the fluid overload severity continuum, fit to help drug development in this area.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Criteria for the Observer Reported Outcomes (ObsRO) cohort of the study:
Inclusion Criteria:
Exclusion Criteria:
1. Index case with dialysis dependence throughout the 3-month pre-enrollment period
Criteria for the Patient Reported Outcomes (PRO) cohort of the study:
Inclusion Criteria:
≥8 years of age
Able to read and understand English
Primary (idiopathic) kidney disease that causes NS or monogenic NS associated kidney disease.
i. Populations with Primary Nephrotic Syndrome (NS) Conditions include: FSGS, MCD, IgM nephropathy, MN, and childhood - onset nephrotic syndrome not biopsied
Current NS-associated edema
Kidney function with most recent estimated Glomerular Filtration Rate (eGFR) > 25 ml/min/1.73m2
Informed Consent: For patients ≥8 to <18 years of age: a parent or legal guardian provide informed consent and the patient must provide assent. Patients ≥18 years of age must provide informed consent.
Exclusion Criteria:
150 participants in 2 patient groups
Loading...
Central trial contact
Ashley Rahimi
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal